The mission of the Child Health Institute of New Jersey is to discover the causes and mechanisms of childhood diseases and to translate our research into prevention, treatment and cure to improve child health in New Jersey, the U.S. and the world.
The Child Health Institute of New Jersey at the Robert Wood Johnson Medical School was founded in the late 1990s with the generous support of the Robert Wood Johnson Foundation and Johnson & Johnson. Our research, academic and clinical building was opened in 2005 as part of the children’s academic health campus in New Brunswick.
Our child-focused, research and clinical care campus includes the Rutgers Robert Wood Johnson Medical School Department of Pediatrics and Pediatric Clinical Research Center, as well as the adjoining Bristol-Myers Squibb Children's Hospital of the Robert Wood Johnson University Hospital, and the PSE&G Children’s Specialized Hospital. The Rutgers Cancer Institute of New Jersey, the only NCI-designated Comprehensive Cancer Center in New Jersey and a leading center for pediatric cancers, is also nearby.
Completed in September 2005, the Child Health Institute building is located on the Rutgers University—New Brunswick campus and includes 40,000 square feet of state-of-the-art laboratories and office space as well as sophisticated facilities for modeling pediatric diseases.
The Child Health Institute has four major research programs in childhood diseases in the areas of inflammation, immune and infectious diseases of childhood; neurodevelopment and autism; pediatric cancers and stem cells; and childhood obesity and metabolism.
Meet CHINJ's Director
Arnold Rabson, MD leads Child Health Institute of New Jersey, and is a professor of Pediatrics, Pharmacology, and Pathology and Laboratory Medicine, in Rutgers Robert Wood Johnson Medical School. His research interests include the pathogenesis of human retroviral infections including HIV and AIDS, and the human T cell leukemia virus, type-1, as well as gene regulation in cancer and development.